Powering Innovation: NIBRT’s Role in Ireland’s Cell and Gene Therapy Future.
The upcoming BioPharmaChem Ireland Budget 2026 places Skills and Innovation at its core, echoing Ibec’s Business Ambition campaign for a competitive, productive and resilient economy.
MORE WAYS TO LISTEN
DownloadThe upcoming BioPharmaChem Ireland Budget 2026 submission places skills and innovation at its core, emphasising the need for public investment and strategic collaboration across the ecosystem to unlock the sector’s full potential.
In the latest episode of Ibec Responds, Dr. Sinead Keogh, Director of Biopharmachem Ireland and Head of Ibec Sectors, is in conversation with Darrin Morrissey, CEO of NIBRT.
Together, they discuss how the institute is helping to realise Ireland’s ambition in cell and gene therapy. From cutting-edge research and world-class talent development to bold initiatives like the Research Ireland Impact Centre proposal, discover how Ireland is positioning itself as a global leader in therapeutics innovation.
Listen / Previous Episodes
Ep. 94 / Ibec Responds
Reaction: Budget 2026
Gerard Brady, Chief Economist, and Mourad Mejdi, Economist, give their reaction and analysis to Budget 2026, detail key measures, and discuss the impact of Budget 2026 on Irish business.
Ep. 93 / Ibec Responds
Q3 2025 Ibec Economic Outlook
In this episode, Gerard Brady discusses key findings from our latest Economic Outlook report with Hazel Ahern-Flynn and Mourad Mejdi.
